Sharkey Howes & Javer continued to hold its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 641 shares of the healthcare conglomerate’s stock at the end of the second quarter. Sharkey Howes & Javer’s holdings in UnitedHealth Group were worth $119,000 as of its most recent filing with the SEC.
Other institutional investors have also recently modified their holdings of the company. Dodge & Cox bought a new stake in UnitedHealth Group during the fourth quarter valued at $1,658,560,000. Norges Bank bought a new stake in UnitedHealth Group during the fourth quarter valued at $1,530,177,000. State Street Corp raised its stake in UnitedHealth Group by 2.5% in the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock valued at $7,499,276,000 after buying an additional 1,122,534 shares in the last quarter. Ameriprise Financial Inc. raised its stake in UnitedHealth Group by 29.9% in the first quarter. Ameriprise Financial Inc. now owns 3,332,761 shares of the healthcare conglomerate’s stock valued at $546,574,000 after buying an additional 766,573 shares in the last quarter. Finally, Swiss National Bank raised its stake in UnitedHealth Group by 25.8% in the first quarter. Swiss National Bank now owns 3,719,488 shares of the healthcare conglomerate’s stock valued at $610,033,000 after buying an additional 763,161 shares in the last quarter. 86.21% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Incorporated (NYSE UNH) traded down 0.38% during midday trading on Wednesday, reaching $193.77. The company’s stock had a trading volume of 1,881,640 shares. The firm has a market cap of $187.35 billion, a P/E ratio of 23.28 and a beta of 0.64. The firm has a 50 day moving average price of $190.13 and a 200-day moving average price of $175.54. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $196.04.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. During the same quarter in the prior year, the company earned $1.96 EPS. The firm’s revenue was up 7.7% on a year-over-year basis. On average, analysts forecast that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be paid a $0.75 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.13%.
TRADEMARK VIOLATION WARNING: This story was published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The correct version of this story can be accessed at https://stocknewstimes.com/2017/08/16/unitedhealth-group-incorporated-nyseunh-stake-held-by-sharkey-howes-javer-updated.html.
Several equities research analysts have recently weighed in on UNH shares. Morgan Stanley raised their price objective on UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 28th. Deutsche Bank AG restated a “buy” rating and issued a $187.00 target price (up previously from $183.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Sanford C. Bernstein restated an “outperform” rating and issued a $190.00 target price on shares of UnitedHealth Group in a report on Monday, July 10th. Oppenheimer Holdings, Inc. restated an “outperform” rating and issued a $205.00 target price (up previously from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Finally, Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday, May 19th. One equities research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $202.20.
In related news, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the completion of the sale, the director now directly owns 60,516 shares in the company, valued at approximately $10,816,629.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $182.64, for a total transaction of $913,200.00. Following the sale, the director now owns 75,735 shares of the company’s stock, valued at $13,832,240.40. The disclosure for this sale can be found here. Insiders sold a total of 15,540 shares of company stock valued at $2,873,320 in the last ninety days. 0.89% of the stock is owned by corporate insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
